Literature DB >> 32074995

Epigenetics of SFRP1: The Dual Roles in Human Cancers.

Rashidah Baharudin1, Francis Yew Fu Tieng1, Learn-Han Lee2, Nurul Syakima Ab Mutalib1.   

Abstract

Secreted frizzled-related protein 1 (SFRP1) is a gene that belongs to the secreted glycoprotein SFRP family. SFRP1 has been classified as a tumor suppressor gene due to the loss of expression in various human cancers, which is mainly attributed by epigenetic inactivation via DNA methylation or transcriptional silencing by microRNAs. Epigenetic silencing of SFRP1 may cause dysregulation of cell proliferation, migration, and invasion, which lead to cancer cells formation, disease progression, poor prognosis, and treatment resistance. Hence, restoration of SFRP1 expression via demethylating drugs or over-expression experiments opens the possibility for new cancer therapy approach. While the role of SFRP1 as a tumor suppressor gene is well-established, some studies also reported the possible oncogenic properties of SFRP1 in cancers. In this review, we discussed in great detail the dual roles of SFRP1 in cancers-as tumor suppressor and tumor promoter. The epigenetic regulation of SFRP1 expression will also be underscored with additional emphasis on the potentials of SFRP1 in modulating responses toward chemotherapeutic and epigenetic-modifying drugs, which may encourage the development of novel drugs for cancer treatment. We also present findings from clinical trials and patents involving SFRP1 to illustrate its clinical utility, extensiveness of each research area, and progression toward commercialization. Lastly, this review provides directions for future research to advance SFRP1 as a promising cancer biomarker.

Entities:  

Keywords:  DNA Methylation; SFRP1; Wnt signaling pathway; cancer biomarkers; gene expression; microRNA

Year:  2020        PMID: 32074995     DOI: 10.3390/cancers12020445

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  19 in total

1.  Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms.

Authors:  Zhenzhen Bai; Qingqing Wu; Cong Zhang; Jing Chen; Liyu Cao
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 2.  SFRP1 Negatively Modulates Pyroptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis: A Review.

Authors:  Ping Jiang; Kai Wei; Cen Chang; Jianan Zhao; Runrun Zhang; Lingxia Xu; Yehua Jin; Linshuai Xu; Yiming Shi; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

3.  Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.

Authors:  Hugh A J Kim; Peter Y F Zeng; Alana Sorgini; Mushfiq H Shaikh; Halema Khan; Danielle MacNeil; Mohammed I Khan; Adrian Mendez; John Yoo; Kevin Fung; Pencilla Lang; David A Palma; Joe S Mymryk; John W Barrett; Krupal B Patel; Paul C Boutros; Anthony C Nichols
Journal:  Head Neck       Date:  2022-02-21       Impact factor: 3.821

4.  Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses.

Authors:  Yimin Li; Shun Lu; Shubin Wang; Xinhao Peng; Jinyi Lang
Journal:  J Transl Med       Date:  2021-05-24       Impact factor: 5.531

5.  Comprehensive Analysis of SFRP Family Members Prognostic Value and Immune Infiltration in Gastric Cancer.

Authors:  Dehua Liu; Chenyu Sun; Nahyun Kim; Chandur Bhan; John Pocholo Whitaker Tuason; Yue Chen; Shaodi Ma; Yuting Huang; Ce Cheng; Qin Zhou; Kaiguang Zhang
Journal:  Life (Basel)       Date:  2021-06-03

6.  Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas.

Authors:  Johannes F Fahrmann; Xiangying Mao; Ehsan Irajizad; Hiroyuki Katayama; Michela Capello; Ichidai Tanaka; Taketo Kato; Ignacio I Wistuba; Anirban Maitra; Edwin J Ostrin; Samir M Hanash; Jody Vykoukal
Journal:  Cancers (Basel)       Date:  2020-05-02       Impact factor: 6.639

7.  Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt/β-catenin signalling pathway via DNA methylation.

Authors:  Yong Li; Lang Wang; Maorui Zhang; Kui Huang; Zhihao Yao; Pengcheng Rao; Xiaoxiao Cai; Jingang Xiao
Journal:  Cell Prolif       Date:  2020-05-28       Impact factor: 6.831

8.  EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines.

Authors:  Yuting Liu; Jun Yu; Yang Xie; Mengying Li; Feng Wang; Jing Zhang; Jian Qi
Journal:  Exp Ther Med       Date:  2020-09-01       Impact factor: 2.447

9.  A Novel Six-Gene Signature for Prognosis Prediction in Ovarian Cancer.

Authors:  Xin Pan; Xiaoxin Ma
Journal:  Front Genet       Date:  2020-10-15       Impact factor: 4.599

10.  DNA methylation analysis with methylation-sensitive high-resolution melting (MS-HRM) reveals gene panel for glioma characteristics.

Authors:  Aleksandra Majchrzak-Celińska; Emilia Dybska; Anna-Maria Barciszewska
Journal:  CNS Neurosci Ther       Date:  2020-08-11       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.